Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccination against self to prevent autoimmune disease: the type 1 diabetes model
Leonard C. Harrison
Immunology and Cell Biology (2008) Vol. 86, Iss. 2, pp. 139-145
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Engineering synthetic vaccines using cues from natural immunity
Darrell J. Irvine, Melody A. Swartz, Gregory L. Szeto
Nature Materials (2013) Vol. 12, Iss. 11, pp. 978-990
Open Access | Times Cited: 539
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
Esther Bandala‐Sanchez, Yuxia Zhang, Simone Reinwald, et al.
Nature Immunology (2013) Vol. 14, Iss. 7, pp. 741-748
Closed Access | Times Cited: 167
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice
Maria Koulmanda, Manoj Bhasin, Lauren Hoffman, et al.
Proceedings of the National Academy of Sciences (2008) Vol. 105, Iss. 42, pp. 16242-16247
Open Access | Times Cited: 162
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance
Andrea Annoni, Brian D. Brown, Alessio Cantore, et al.
Blood (2009) Vol. 114, Iss. 25, pp. 5152-5161
Open Access | Times Cited: 126
The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes
Pjotr Bekkering, Ismael Jafri, Frans J. van Overveld, et al.
Expert Review of Clinical Immunology (2013) Vol. 9, Iss. 11, pp. 1031-1041
Closed Access | Times Cited: 72
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis
Jonathan Cho, Joshua M. Stewart, Theodore T. Drashansky, et al.
Biomaterials (2017) Vol. 143, pp. 79-92
Open Access | Times Cited: 72
Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives
AG Ziegler, Thomas Danne, David B. Dunger, et al.
Molecular Metabolism (2016) Vol. 5, Iss. 4, pp. 255-262
Open Access | Times Cited: 59
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica
Melina Jones, Hwa Huang, Peter A. Calabresi, et al.
Acta Neuropathologica Communications (2015) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Type 1 diabetes: Lessons for other autoimmune diseases?
Leonard C. Harrison, Margo C. Honeyman, Grant Morahan, et al.
Journal of Autoimmunity (2008) Vol. 31, Iss. 3, pp. 306-310
Closed Access | Times Cited: 60
Combinatorial drug delivery approaches for immunomodulation
Joshua M. Stewart, Benjamin G. Keselowsky
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 161-174
Open Access | Times Cited: 46
Direct modulation of myelin-autoreactive CD4<sup>+</sup> and CD8<sup>+</sup> T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
Weiya Pei, Xin Wan, Khawar Ali Shahzad, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 3731-3750
Open Access | Times Cited: 43
Trials in type 1 diabetes: Antigen-specific therapies
Ken Coppieters, Leonard C. Harrison, Matthias G. von Herrath
Clinical Immunology (2013) Vol. 149, Iss. 3, pp. 345-355
Open Access | Times Cited: 41
Antigen-Based Vaccination and Prevention of Type 1 Diabetes
Leonard C. Harrison, John M. Wentworth, Yuxia Zhang, et al.
Current Diabetes Reports (2013) Vol. 13, Iss. 5, pp. 616-623
Closed Access | Times Cited: 39
Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines
Amy Galliher-Beckley, Loretta Pappan, Rachel Madera, et al.
Vaccine (2015) Vol. 33, Iss. 25, pp. 2903-2908
Open Access | Times Cited: 36
Helminth Infection and Type 1 Diabetes
Paola Zaccone, Samuel W. Hall
The Review of Diabetic Studies (2012) Vol. 9, Iss. 4, pp. 272-286
Open Access | Times Cited: 36
Revisiting regulatory T cells in type 1 diabetes
Yuxia Zhang, Esther Bandala‐Sanchez, Leonard C. Harrison
Current Opinion in Endocrinology Diabetes and Obesity (2012) Vol. 19, Iss. 4, pp. 271-278
Closed Access | Times Cited: 34
Antigen-Based Therapy for the Treatment of Type 1 Diabetes
Jide Tian, Daniel L. Kaufman
Diabetes (2009) Vol. 58, Iss. 9, pp. 1939-1946
Open Access | Times Cited: 36
Helminth mediated modulation of Type 1 diabetes (T1D)
Paola Zaccone, Anne Cooke
International Journal for Parasitology (2013) Vol. 43, Iss. 3-4, pp. 311-318
Open Access | Times Cited: 29
Generation and expansion of regulatory human CD4+ T-cell clones specific for pancreatic islet autoantigens
James A. Dromey, Bo Han Lee, Hua Yu, et al.
Journal of Autoimmunity (2010) Vol. 36, Iss. 1, pp. 47-55
Closed Access | Times Cited: 28
Making progress: preserving beta cells in type 1 diabetes
Mary Gallagher, Robin Goland, Carla J. Greenbaum
Annals of the New York Academy of Sciences (2011) Vol. 1243, Iss. 1, pp. 119-134
Closed Access | Times Cited: 27
Autoantigen based vaccines for type 1 diabetes.
Dequina Nicholas, Oludare Odumosu, William H. R. Langridge
PubMed (2011)
Closed Access | Times Cited: 23
Non-antigenic and antigenic interventions in type 1 diabetes
Anna Rydén, Johnna D. Wesley, Ken Coppieters, et al.
Human Vaccines & Immunotherapeutics (2013) Vol. 10, Iss. 4, pp. 838-846
Open Access | Times Cited: 21
The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes
Leonard C. Harrison
Molecular Metabolism (2021) Vol. 52, pp. 101288-101288
Open Access | Times Cited: 15
Infectious triggers protect from autoimmunity
Paola Zaccone, Anne Cooke
Seminars in Immunology (2011) Vol. 23, Iss. 2, pp. 122-129
Closed Access | Times Cited: 19
Recent advances in DNA vaccines for autoimmune diseases
Célio Lopes Silva, Vânia Luiza Deperon Bonato, R.R. Santos-Junior, et al.
Expert Review of Vaccines (2009) Vol. 8, Iss. 2, pp. 239-252
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top